Why the study?
Cytoreductive surgery in late-stage ovarian cancer is challenging due to volume shifts, and altered vasoactive mediators may affect systemic vascular function.
How do serum levels of vasoactive markers and mediators change during cytoreductive surgery in late-stage ovarian cancer patients?
How do serum levels of vasoactive markers and mediators change during cytoreductive surgery in late-stage ovarian cancer patients?
Cytoreductive surgery in late-stage ovarian cancer induces a proinflammatory serum profile that promotes vascular leakage, potentially contributing to observed hemodynamic alterations.
Answers are grounded in this paper and cite their sources.
Changes in IL-6/ANGPT2 during ovarian CS were associated with leakage-promoting profiles; leaves open whether targeting them mitigates fluid shifts.
BACKGROUND: Cytoreductive surgery (CS) in late-stage ovarian cancer patients is often challenging due to extensive volume shifts, and high fluid intake may provoke postoperative complications. Expression of vasoactive mediators is altered in cancer patients, which may affect systemic vascular function. We sought to assess how serum levels of vasoactive markers and mediators change during CS in ovarian cancer. METHODS: Following IRB approval and informed consent, pre- and postoperative serum samples were analyzed in 26 late-stage ovarian cancer patients using multiplex protein arrays and ELISA. RESULTS: The proinflammatory cytokines and chemokines IL-6, IL-8, and CCL2 were significantly elevated after 24 hrs compared to the baseline values, with IL-6 and IL-8 being most prominently increased. While ANGPT1 remained unchanged after surgery, its competitive antagonist ANGPT2 was significantly increased. In contrast, serum levels of the ANGPT receptor TIE2 were decreased to 0.6 of the baseline values. While VEGF-D, E-selectin, P-selectin, ICAM-1, and PECAM-1 remained unchanged, serum activity of both thrombomodulin and syndecan-1 was significantly increased following surgery. CONCLUSION: We identified a regulatory network of acute-phase reaction during CS in late-stage ovarian cancer. This suggests that IL-6 exerts positive regulation of other proinflammatory mediators and, by upregulating ANGPT2 and suppressing ANGPT1, induces a serum profile that promotes vascular leakage. This may contribute to the observed hemodynamic alterations during CS procedures.
No takes yet. Share an insight, caveat, or question.
Klaschik et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: